CannaNova uses patented DepoFilm™ thin film technology to deliver superior cannabinoid products for the adult consumer
Advanced Cannabinoid
Consumables
CannaNova uses patented DepoFilm™ thin film technology to deliver superior cannabinoid products for the adult consumer
CannaNova is a specialty consumer health company that develops and manufactures dissolving cannabinoid thin films using patented DepoFilm™ technology
About
Сonsumer health company
About
CannaNova patented film technology DepoFilm™
Founded by pharma entrepreneurs who helped to create and establish the modern soluble thin film drug delivery industry, CannaNova brings together advanced formulation techniques, next generation manufacturing technology and experienced management to develop and manufacture high performance cannabinoid thin film products for adult consumers. CannaNova is based in North Carolina.
Existing cannabinoid edible products face problems like slow-uptake, low overall bioavailability, and high variability in absorption from use to use. CannaNova solves these issues through our patented film technology, DepoFilm™.
Oral Liquid/Triturate
Soluble Film
Orodispersible tablet
Chewable tablet
Powder /
Triturate
Triturate
Swallowable tablet/capsule
Buccal Soluble Films are ideal for adults where discreet use and portability are important.
In human clinical trials, CannaNova has demonstrated up to 3x bioavailability improvement versus conventional oral products.
Buccal Soluble Film offers more rapid absorption and improved overall bioavailability. This translates to products that offer rapid relief, and the ability of adult users to titrate their desired cannabinoid dosing.
Buccal Soluble Film products have found very successful application in systemic drug delivery by sublingual or buccal routes to avoid hepatic first-pass metabolism, GI digestion, and gut-wall metabolism.
Technology
Cannanova's state of the art Buccal Soluble Film technology is multi-functional. It is the ultimate vehicle for cannabinoid delivery possessing the virtues of both edibles and tinctures. The films are elegant, compact, slim, portable, stable, non-fragile, non-caloric unit dosages containing a precise dose that is rapidly absorbed directly into the blood via the buccal/sublingual route.
Buccal soluble film technology
These attributes make DepoFilm™ uniquely positioned to solve the delivery challenges posed by cannabinoid products. DepoFilm™ enables cannabinoid formulations for adults with rapid absorption, and improved bioavailability. DepoFilm™ cannabinoid formulations taste good and are easy to use. They can be used by adults in a discreet manner, and are easier to dose-adjust.
Patented DepoFilm™ technology is a disruptive advancement in OSF drug delivery with marked improvements in development timelines, manufacturing efficiency and formulation. DepoFilm™ opens new vistas in OSF for new, functional shapes, and novel multi-layer compositions, in each case in a single integrated manufacturing process that includes film formation through completion of primary, consumer-ready packaging.
Technology
DepoFilm™ Technology
US 11,219,599
US 10,238,600
US 11,173,114
US 11,090,262
US 10,195,142
US 9,901,545
TECHNOLOGY |
products
Advanced Cannabinoid products
Delta-8 THC 15 mg Mint Mocha Latte
Delta-8 THC 20 mg Mint Mocha Latte
We publish our latest news, upcoming events, and special offers
News
Current news CannaNova
We really love to communicate with our clients.
Feel free to Contact us
info@cannnova.com
CannaNova LLC
8646 W Market St, Suite 110, Greensboro NC 27409
8646 W Market St, Suite 110, Greensboro NC 27409
General Contact
distribution@cannanova.com
Retailers and Distributors’ Contact